Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-058458

Chief Financial Officer bought 11,829 shares at an average $0.95 ($11,241)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quinn William P. Chief Financial Officer 2023-06-06 Purchase +1,829 $1.18 $2,161 26,272 D
Quinn William P. Chief Financial Officer 2023-12-06 Purchase +2,500 $0.78 $1,955 28,772 D
Quinn William P. Chief Financial Officer 2023-12-12 Purchase +7,500 $0.95 $7,125 36,272 D
Open-market purchases · 11,829 sh · avg $0.95 · $11,241
Loading xslF345X05/doc4.xml…